Fox Chase Cancer Center News

PHILADELPHIA (August 23, 2018) – As part of its ongoing commitment to community health, Fox Chase Cancer Center is pleased to support Miles for Melanoma 2018 in Philadelphia. Faculty and staff, volunteers, patients, survivors, and their families will come together at this family-friendly 5K run/walk to raise funds to support melanoma research, education, and advocacy through the Melanoma Research Foundation.

PHILADELPHIA (August 22, 2018)— Jeffrey Farma, MD, surgical oncologist at Fox Chase Cancer Center, has been appointed chief of the Division of General Surgery within the Department of Surgery.

PHILADELPHIA (August 21, 2018)— Michael J. Hall, MD, MS, interim chair of Clinical Genetics at Fox Chase Cancer Center, has received an American Cancer Society research grant to improve understanding and communication of genetic risk information among physicians and cancer patients.

PHILADELPHIA (August 20, 2018)— Martin J. Edelman, MD, chair of the department of Hematology/Oncology, has received a Translational Research Partnership Award in collaboration with Creatv Microtech,  from the U.S. Department of Defense to develop a test for early detection of early stage lung cancer.

PHILADELPHIA (August 15, 2018) – Used to view the inside of the lungs and obtain a tissue sample for biopsy, the goal of Auris Health’s  Monarch™ Platform is to enable earlier and more accurate diagnosis of small and hard-to-reach nodules in the periphery of the lung.

PHILADELPHIA (August 15, 2018) – Fox Chase Cancer Center is pleased to announce the hiring of Julio Noriega, MD, as an assistant professor in the Division of Pulmonary, Critical Care, and Sleep Medicine.

PHILADELPHIA (August 15, 2018) – Fox Chase Cancer Center is pleased to announce the hiring of Jennifer Tome Higa, MD, as an interventional gastroenterologist in the Department of Medicine.

PHILADELPHIA (August 14, 2018) — Warren Kruger, PhD, a professor of cancer biology at Fox Chase Cancer Center, recently published a study in the journal Cancer Research describing a promising new combination therapy approach to killing tumor cells while sparing healthy cells.